Company

Avammune Therapeutics

Rocket Ship Rating

Rocket Ship Rating: 78 out of 100

Multi-Modal Cancer Therapies

Biotech & therapeutics

Status: Operatingas of 2026-09-18
Business model: B2B
Customers: POC-driven partnerships
Legal name: Avammune Therapeutics

avammune.com (opens in a new tab)
Press page (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 18 September 2026

About

Avammune is an R&D-driven drug discovery company developing novel modality-agnostic best-in-class and first-in-class therapies for hard-to-treat solid tumors.

Investor VC firms in this preview

Capital2b
Redstart Labs
Shastra VC

VC firm
Company
Partner

VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.

Avammune Therapeutics

About

Relationship map preview

Relationship map preview